These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 8597155)

  • 41. Studies of ochratoxin A-induced inhibition of phenylalanine hydroxylase and its reversal by phenylalanine.
    Zanic-Grubisić T; Zrinski R; Cepelak I; Petrik J; Radić B; Pepeljnjak S
    Toxicol Appl Pharmacol; 2000 Sep; 167(2):132-9. PubMed ID: 10964764
    [TBL] [Abstract][Full Text] [Related]  

  • 42. PCV2 infection aggravates ochratoxin A-induced nephrotoxicity via autophagy involving p38 signaling pathway in vivo and in vitro.
    Gan F; Zhou Y; Qian G; Huang D; Hou L; Liu D; Chen X; Wang T; Jiang P; Lei X; Huang K
    Environ Pollut; 2018 Jul; 238():656-662. PubMed ID: 29614475
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ochratoxin A and β2-microglobulin in BEN patients and controls.
    Yordanova P; Wilfried K; Tsolova S; Dimitrov P
    Toxins (Basel); 2010 Apr; 2(4):780-92. PubMed ID: 22069610
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ochratoxin A from a toxicological perspective.
    Petzinger E; Ziegler K
    J Vet Pharmacol Ther; 2000 Apr; 23(2):91-8. PubMed ID: 10849253
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Alterations induced in vitro by ochratoxin A in rat lymphoid cells.
    Alvarez-Erviti L; Leache C; González-Peñas E; de Cerain AL
    Hum Exp Toxicol; 2005 Sep; 24(9):459-66. PubMed ID: 16235735
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Selective toxicity of ochratoxin A in primary cultures from different brain regions.
    Belmadani A; Steyn PS; Tramu G; Betbeder AM; Baudrimont I; Creppy EE
    Arch Toxicol; 1999 Mar; 73(2):108-14. PubMed ID: 10350191
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inactivation of A. ochraceus spores and detoxification of ochratoxin A in coffee beans by gamma irradiation.
    Kumar S; Kunwar A; Gautam S; Sharma A
    J Food Sci; 2012 Feb; 77(2):T44-51. PubMed ID: 22339551
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Biodegradation of ochratoxin a for food and feed decontamination.
    Abrunhosa L; Paterson RR; Venâncio A
    Toxins (Basel); 2010 May; 2(5):1078-99. PubMed ID: 22069627
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ochratoxin A in human kidney diseases.
    Fuchs R; Peraica M
    Food Addit Contam; 2005; 22 Suppl 1():53-7. PubMed ID: 16332622
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ochratoxin A: induction of (oxidative) DNA damage, cytotoxicity and apoptosis in mammalian cell lines and primary cells.
    Kamp HG; Eisenbrand G; Schlatter J; Würth K; Janzowski C
    Toxicology; 2005 Jan; 206(3):413-25. PubMed ID: 15588931
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Heat shock proteins (Hsp 70) response is not systematic to cell stress: case of the mycotoxin ochratoxin A.
    Hassen W; Ayed-Boussema I; Bouslimi A; Bacha H
    Toxicology; 2007 Dec; 242(1-3):63-70. PubMed ID: 17981385
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ochratoxin A and aristolochic acid involvement in nephropathies and associated urothelial tract tumours.
    Pfohl-Leszkowicz A
    Arh Hig Rada Toksikol; 2009 Dec; 60(4):465-83. PubMed ID: 20061248
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Biotransformation and nephrotoxicity of ochratoxin B in rats.
    Mally A; Keim-Heusler H; Amberg A; Kurz M; Zepnik H; Mantle P; Völkel W; Hard GC; Dekant W
    Toxicol Appl Pharmacol; 2005 Aug; 206(1):43-53. PubMed ID: 15963343
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The role of ochratoxin A as a possible cause of Balkan endemic nephropathy and its risk evaluation.
    Stoev SD
    Vet Hum Toxicol; 1998 Dec; 40(6):352-60. PubMed ID: 9830698
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ochratoxin A and Kidney Oxidative Stress: The Role of Nutraceuticals in Veterinary Medicine-A Review.
    Longobardi C; Ferrara G; Andretta E; Montagnaro S; Damiano S; Ciarcia R
    Toxins (Basel); 2022 Jun; 14(6):. PubMed ID: 35737059
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A journey through mitogen-activated protein kinase and ochratoxin A interactions.
    Rumora L; Grubisić TZ
    Arh Hig Rada Toksikol; 2009 Dec; 60(4):449-56. PubMed ID: 20061246
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Presence of ochratoxin A in Tunisian blood nephropathy patients. Exposure level to OTA.
    Zaied C; Bouaziz C; Azizi I; Bensassi F; Chour A; Bacha H; Abid S
    Exp Toxicol Pathol; 2011 Nov; 63(7-8):613-8. PubMed ID: 20708395
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of quercetin on the toxicokinetics of ochratoxin A in rats.
    Abbas Z; Blank R; Wein S; Wolffram S
    Food Addit Contam Part A Chem Anal Control Expo Risk Assess; 2013; 30(5):861-6. PubMed ID: 23724859
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ochratoxin A carcinogenicity involves a complex network of epigenetic mechanisms.
    Marin-Kuan M; Cavin C; Delatour T; Schilter B
    Toxicon; 2008 Aug; 52(2):195-202. PubMed ID: 18649906
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Foodstuffs and human blood contamination by the mycotoxin ochratoxin A: correlation with chronic interstitial nephropathy in Tunisia.
    Maaroufi K; Achour A; Betbeder AM; Hammami M; Ellouz F; Creppy EE; Bacha H
    Arch Toxicol; 1995; 69(8):552-8. PubMed ID: 8534199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.